1. Home
  2. IBRX

IBRX

ImmunityBio Inc.

Logo ImmunityBio Inc.

Health Care

Biotechnology: Biological Products (No Diagnostic Substances)

Nasdaq

as 04-12-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
-
.
-
-
%

ImmunityBio Inc is a late-clinical-stage immunotherapy company developing next-generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. Geographically, the company operates in United States and Europe. Majority of the revenue is generated from Europe.

Founded: 2014 Country:
United States
United States
Employees: N/A City: SAN DIEGO
Market Cap: 4.1B IPO Year: N/A
Target Price: $5.00 AVG Volume (30 days): 4.1M
Analyst Decision: Hold Number of Analysts: 1
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.15 EPS Growth: N/A
52 Week Low/High: $1.25 - $6.93 Next Earning Date: 05-09-2024
Revenue: $622,000 Revenue Growth: 159.17%
Revenue Growth (this year): 1487.46% Revenue Growth (next year): 774.76%

Share on Social Networks: